200 related articles for article (PubMed ID: 29118984)
1. Clinical trial protocol for TARDOX: a phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin (ThermoDox®) using focused ultrasound in patients with liver tumours.
Lyon PC; Griffiths LF; Lee J; Chung D; Carlisle R; Wu F; Middleton MR; Gleeson FV; Coussios CC
J Ther Ultrasound; 2017; 5():28. PubMed ID: 29118984
[TBL] [Abstract][Full Text] [Related]
2. Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasound.
Spiers L; Gray M; Lyon P; Sivakumar S; Bekkali N; Scott S; Collins L; Carlisle R; Wu F; Middleton M; Coussios C
BMC Cancer; 2023 Sep; 23(1):896. PubMed ID: 37741968
[TBL] [Abstract][Full Text] [Related]
3. Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial.
Lyon PC; Gray MD; Mannaris C; Folkes LK; Stratford M; Campo L; Chung DYF; Scott S; Anderson M; Goldin R; Carlisle R; Wu F; Middleton MR; Gleeson FV; Coussios CC
Lancet Oncol; 2018 Aug; 19(8):1027-1039. PubMed ID: 30001990
[TBL] [Abstract][Full Text] [Related]
4. Focused Ultrasound Hyperthermia for Targeted Drug Release from Thermosensitive Liposomes: Results from a Phase I Trial.
Gray MD; Lyon PC; Mannaris C; Folkes LK; Stratford M; Campo L; Chung DYF; Scott S; Anderson M; Goldin R; Carlisle R; Wu F; Middleton MR; Gleeson FV; Coussios CC
Radiology; 2019 Apr; 291(1):232-238. PubMed ID: 30644817
[TBL] [Abstract][Full Text] [Related]
5. Phase I feasibility study of Magnetic Resonance guided High Intensity Focused Ultrasound-induced hyperthermia, Lyso-Thermosensitive Liposomal Doxorubicin and cyclophosphamide in
de Maar JS; Suelmann BBM; Braat MNGJA; van Diest PJ; Vaessen HHB; Witkamp AJ; Linn SC; Moonen CTW; van der Wall E; Deckers R
BMJ Open; 2020 Nov; 10(11):e040162. PubMed ID: 33243800
[TBL] [Abstract][Full Text] [Related]
6. Large-Volume Hyperthermia for Safe and Cost-Effective Targeted Drug Delivery Using a Clinical Ultrasound-Guided Focused Ultrasound Device.
Lyon PC; Mannaris C; Gray M; Carlisle R; Gleeson FV; Cranston D; Wu F; Coussios CC
Ultrasound Med Biol; 2021 Apr; 47(4):982-997. PubMed ID: 33451816
[TBL] [Abstract][Full Text] [Related]
7. Enhanced drug delivery in rabbit VX2 tumours using thermosensitive liposomes and MRI-controlled focused ultrasound hyperthermia.
Staruch RM; Ganguly M; Tannock IF; Hynynen K; Chopra R
Int J Hyperthermia; 2012; 28(8):776-87. PubMed ID: 23153219
[TBL] [Abstract][Full Text] [Related]
8. Hyperthermia-mediated doxorubicin release from thermosensitive liposomes using MR-HIFU: therapeutic effect in rabbit Vx2 tumours.
Staruch RM; Hynynen K; Chopra R
Int J Hyperthermia; 2015 Mar; 31(2):118-33. PubMed ID: 25582131
[TBL] [Abstract][Full Text] [Related]
9. Lyso-thermosensitive liposomal doxorubicin for treatment of bladder cancer.
Mikhail AS; Negussie AH; Pritchard WF; Haemmerich D; Woods D; Bakhutashvili I; Esparza-Trujillo J; Brancato SJ; Karanian J; Agarwal PK; Wood BJ
Int J Hyperthermia; 2017 Nov; 33(7):733-740. PubMed ID: 28540814
[TBL] [Abstract][Full Text] [Related]
10. Focused Ultrasound Hyperthermia Mediated Drug Delivery Using Thermosensitive Liposomes and Visualized With
Santos MA; Goertz DE; Hynynen K
Theranostics; 2017; 7(10):2718-2731. PubMed ID: 28819458
[TBL] [Abstract][Full Text] [Related]
11. Triggered radiosensitizer delivery using thermosensitive liposomes and hyperthermia improves efficacy of radiotherapy: An in vitro proof of concept study.
Besse HC; Bos C; Zandvliet MMJM; van der Wurff-Jacobs K; Moonen CTW; Deckers R
PLoS One; 2018; 13(9):e0204063. PubMed ID: 30226898
[TBL] [Abstract][Full Text] [Related]
12. Image-guided thermosensitive liposomes for focused ultrasound drug delivery: Using NIRF-labelled lipids and topotecan to visualise the effects of hyperthermia in tumours.
Centelles MN; Wright M; So PW; Amrahli M; Xu XY; Stebbing J; Miller AD; Gedroyc W; Thanou M
J Control Release; 2018 Jun; 280():87-98. PubMed ID: 29723616
[TBL] [Abstract][Full Text] [Related]
13. Drug development of lyso-thermosensitive liposomal doxorubicin: Combining hyperthermia and thermosensitive drug delivery.
Borys N; Dewhirst MW
Adv Drug Deliv Rev; 2021 Nov; 178():113985. PubMed ID: 34555486
[TBL] [Abstract][Full Text] [Related]
14. Increased Duration of Heating Boosts Local Drug Deposition during Radiofrequency Ablation in Combination with Thermally Sensitive Liposomes (ThermoDox) in a Porcine Model.
Swenson CE; Haemmerich D; Maul DH; Knox B; Ehrhart N; Reed RA
PLoS One; 2015; 10(10):e0139752. PubMed ID: 26431204
[TBL] [Abstract][Full Text] [Related]
15. Closed-loop trans-skull ultrasound hyperthermia leads to improved drug delivery from thermosensitive drugs and promotes changes in vascular transport dynamics in brain tumors.
Kim C; Guo Y; Velalopoulou A; Leisen J; Motamarry A; Ramajayam K; Aryal M; Haemmerich D; Arvanitis CD
Theranostics; 2021; 11(15):7276-7293. PubMed ID: 34158850
[TBL] [Abstract][Full Text] [Related]
16. The effect of injected dose on localized tumor accumulation and cardiac uptake of doxorubicin in a Vx2 rabbit tumor model using MR-HIFU mild hyperthermia and thermosensitive liposomes.
Cheng B; Bing C; Staruch RM; Shaikh S; Wodzak Staruch M; Szczepanski D; Williams NS; Laetsch TW; Chopra R
Int J Hyperthermia; 2020; 37(1):1052-1059. PubMed ID: 32892667
[TBL] [Abstract][Full Text] [Related]
17. Hyperthermia-induced doxorubicin delivery from thermosensitive liposomes via MR-HIFU in a pig model.
Sebeke LC; Castillo Gómez JD; Heijman E; Rademann P; Simon AC; Ekdawi S; Vlachakis S; Toker D; Mink BL; Schubert-Quecke C; Yeo SY; Schmidt P; Lucas C; Brodesser S; Hossann M; Lindner LH; Grüll H
J Control Release; 2022 Mar; 343():798-812. PubMed ID: 35134460
[TBL] [Abstract][Full Text] [Related]
18. MR-labelled liposomes and focused ultrasound for spatiotemporally controlled drug release in triple negative breast cancers in mice.
Amrahli M; Centelles M; Cressey P; Prusevicius M; Gedroyc W; Xu XY; So PW; Wright M; Thanou M
Nanotheranostics; 2021; 5(2):125-142. PubMed ID: 33457192
[No Abstract] [Full Text] [Related]
19. Interleaved Mapping of Temperature and Longitudinal Relaxation Rate to Monitor Drug Delivery During Magnetic Resonance-Guided High-Intensity Focused Ultrasound-Induced Hyperthermia.
Kneepkens E; Heijman E; Keupp J; Weiss S; Nicolay K; Grüll H
Invest Radiol; 2017 Oct; 52(10):620-630. PubMed ID: 28598900
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
